Incidence and Nature of Short-Term Adverse Events following COVID-19 Second Boosters: Insights from Taiwan's Universal Vaccination Strategy.

Although the influence of vaccine brand choice did not reach statistical significance (incidence rate ratio, 2.03, p = 0.051), there was a trend indicating that participants receiving mRNA1273 had a higher incidence rate of adverse events ( Figure 2 ).

also in 111,027 other papers